Skip to content
DataLookout
Menu

NCT06314048

4T Sustainability Program

StatusWithdrawn
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Enrolling by Invitation → Withdrawn Sponsor's reason: The study was determined to be non-human subject research and quality improvement program. Show 4 more changesShow less
    • Enrollment target: estimated 5000 to confirmed 0
    • Eligibility criteria expanded, about 10 words
    • Site details revised
    • Study description expanded, about 2 words
  2. Notable Primary completion date: Jan 2026 to Jan 31, 2027
    • Study completion date: Jan 2026 to Jan 31, 2028
    v5
  3. Minor Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v4
  4. Notable Phase: Not applicable to Not specified
    • Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2024 to May 30, 2024
    v3
  5. Minor Start date: Mar 2024 to Apr 2024v2
  6. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

HbA1c trajectory observed 4-12 months post-diagnosis
Timeframe: 4-12 months post TID diagnosis
Diabetes distress measured at baseline and 12 months post-diagnosis.
Timeframe: baseline and 12 months post Type 1 Diabetes diagnosis

Arms and interventions

Standard of Care - CGM and RPM

1\. Implement the 4T program as standard of care at Stanford Diabetes clinics, including Continuous Glucose Monitoring (CGM) and Remote Patient Monitoring (RPM) within the first 30 days after T1D diagnosis to reduce the rise in HbA1c trajectory observed 4-12 months post-diagnosis.

Other: CGM and RPM

Sites

1 site in 1 country

  • Lucile Packard Children's HospitalPalo Alto, California, United States